SWK
Stephen W. Kidder Portfolio holdings
AUM
$333M
This Quarter Return
+1.25%
1 Year Return
+13.37%
3 Year Return
+68.68%
5 Year Return
+109.64%
10 Year Return
+277.6%
AUM
$124M
AUM Growth
–
Cap. Flow
+$124M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
37.21%
Holding
69
New
69
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$5.16M |
| 2 |
Procter & Gamble
PG
|
$5.07M |
| 3 |
3M
MMM
|
$4.8M |
| 4 |
Canadian National Railway
CNI
|
$4.65M |
| 5 |
Novartis
NVS
|
$4.56M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 22.41% |
| 2 | Industrials | 18.14% |
| 3 | Technology | 17.9% |
| 4 | Energy | 12.35% |
| 5 | Consumer Staples | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merck
MRK
$212B
| $277K | 0.22% |
+5,973
| New | +$277K |
|
52
IBM
IBM
$224B
| $245K | 0.2% |
+1,280
| New | +$245K |
|
53
J.M. Smucker
SJM
$11.6B
| $245K | 0.2% |
+2,370
| New | +$245K |
|
54
Corning
GLW
$58.3B
| $239K | 0.19% |
+16,800
| New | +$239K |
|
55
Ovintiv
OVV
$10.9B
| $222K | 0.18% |
+13,165
| New | +$222K |
|
56
Colgate-Palmolive
CL
$67.9B
| $212K | 0.17% |
+3,710
| New | +$212K |
|
57
Novo Nordisk
NVO
$249B
| $210K | 0.17% |
+1,352
| New | +$210K |
|
58
GSK
GSK
$77.9B
| $206K | 0.17% |
+4,125
| New | +$206K |
|
|
B
59
Barrick Mining Corporation
B
$46.2B
| $189K | 0.15% |
+12,000
| New | +$189K |
|
|
FCSE
60
DELISTED
FOCUS ENHANCEMENTS INC
FCSE
| $0 | ﹤0.01% |
+11,500
| New | – |
|